Periodontitis is a chronic inflammatory disease characterized by progressive destruction of the periodontal tissues, including the periodontal ligament and alveolar bone, driven by dysregulated host immune responses to bacterial challenge. Although co...
Periodontitis is a chronic inflammatory disease characterized by progressive destruction of the periodontal tissues, including the periodontal ligament and alveolar bone, driven by dysregulated host immune responses to bacterial challenge. Although conventional periodontal therapies focus on mechanical debridement and infection control, these approaches have limitations in preventing sustained inflammation and subsequent bone loss. Therefore, there is growing interest in host-modulatory strategies using natural products with anti-inflammatory and bone-protective properties.
Pimpinella brachycarpa is a traditional medicinal plant known for its anti-inflammatory and antioxidant activities; however, its therapeutic potential and underlying mechanisms in periodontitis remain insufficiently understood. The present dissertation aimed to comprehensively evaluate the anti-inflammatory and bone-protective effects of Pimpinella brachycarpa extract (PBE) using complementary rat models of periodontitis and to elucidate its mechanistic basis through integrated in vivo and in vitro approaches.
First, the therapeutic efficacy of PBE was evaluated in a ligature-induced rat model of periodontitis, which closely mimics the complex pathological features of clinical periodontal disease. PBE administration significantly attenuated alveolar bone loss and preserved periodontal tissue architecture. Histological and immunohistochemical analyses demonstrated reduced osteoclast activity, decreased infiltration of inflammatory immune cells, and suppressed expression of pro-inflammatory cytokines in periodontal tissues. These findings indicate that PBE exerts protective effects against periodontal tissue destruction under multifactorial inflammatory conditions.
To further investigate the inflammation-driven mechanisms of PBE, an LPS-induced rat model of periodontitis and cell-based experiments were employed. In this model, PBE significantly reduced alveolar bone loss, osteoclast activation, and disease activity scores. In vitro studies using macrophages and human periodontal ligament fibroblasts revealed that PBE suppressed the production of inflammatory mediators and cytokines induced by LPS or interleukin-1β stimulation. Moreover, PBE inhibited the activation of key inflammatory signaling pathways, including the PI3K/AKT and NF-κB pathways, and reduced the expression of matrix metalloproteinases associated with extracellular matrix degradation.
Collectively, this dissertation demonstrates that PBE effectively mitigates periodontal inflammation and alveolar bone destruction in rat models of periodontitis by modulating inflammatory responses and osteoclast activity. These findings provide both phenotypic and mechanistic evidence supporting the potential of PBE as a natural host-modulatory agent for the adjunctive management of periodontitis.